Our previous studies have demonstrated that the intratumoral angiogenesis and tumor growth of OVCA can be suppressed with adenovirus-mediated expression of soluble VEGFR (sVEGFR) decoys that bind VEGFs and inhibit VEGF/VEGFR signaling pathway in a mouse model (6–9). The gene discussed is KDR; the disease is neoplasm.